NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Sept. 5, 2006--Acacia Research Corporation (Nasdaq:CBMX) (Nasdaq:ACTG) announced today that its CombiMatrix group’s subsidiary, CombiMatrix Molecular Diagnostics (CMDX) has commercially launched its first molecular diagnostic service. Physicians are now able to prescribe this test for their patients.
